Update in perioperative medicine

Journal of General Internal Medicine

Volumn 21, Issue 12, 2006, Pages 1329-1337

  Smetana, Gerald W ^a,e   Cohn, Steven L ^b   Mercado, Donna L ^c   Jaffer, Amir K ^d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Intraoperative complications; Postoperative complications; Preoperative care; Surgery; Venous thromboembolism

Indexed keywords

ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DALTEPARIN; ENOXAPARIN; FONDAPARINUX; HALOPERIDOL;

ABDOMINAL SURGERY; BARIATRIC SURGERY; BLEEDING; BRADYCARDIA; CANCER SURGERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONGESTIVE HEART FAILURE; DATA BASE; DELIRIUM; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG USE; HEALTH INSURANCE; HEART MUSCLE REVASCULARIZATION; HIGH RISK POPULATION; HUMAN; HYPOTENSION; KIDNEY FAILURE; LUNG COMPLICATION; MEDICAID; MORBIDITY; NASOGASTRIC TUBE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; REVIEW; RISK REDUCTION; THORACOTOMY; THORAX RADIOGRAPHY; UNSPECIFIED SIDE EFFECT; VENOUS THROMBOEMBOLISM;

BARIATRIC SURGERY; CARDIAC SURGICAL PROCEDURES; DELIRIUM; HUMANS; INTRAOPERATIVE CARE; LUNG; PERIOPERATIVE CARE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RISK REDUCTION BEHAVIOR; SURGICAL PROCEDURES, OPERATIVE; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 33750543319     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1111/j.1525-1497.2006.00630.x     Document Type: Review

References (23)

1. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043-9.
2. Wilson SH, Fasseas P, Orford JL, et al. Clinical outcomes of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol. 2003;42:234-40.
3. Kaluza GL, Joseph J, Lee JR, Raizner ME, Raizner AE Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol. 2000;35:1288-94.
4. Eagle K, Berger P, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation. 2002;105:1257-6.
5. Poldermans D, Boersma E, Bax J, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med. 1999;341:1789-94.
6. Mangano DT, Layug EL, Wallace A, Tateo I., for the Multicenter Study of Perioperative Ischemia Research Group. Effect of atenolol on mortality and cardiovascular mortality after noncardiac surgery. N Engl J Med. 1996;335:1713-20.
7. Juul A, Wetterslev J, Gluud C, et al. Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ. 2006;332:1482.
8. Yang H, Raymer K, Butler R, et al. Metoprolol after Vascular Surgery (MaVS) [abstract]. Can J Anaesth. 2004;51:A7.
9. Fleisher L, Beckman J, Brown K, et al. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology. Circulation. 2006;113:2662-74.
10. Schwartz G, Olsson A, Ezekowitz M, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA. 2001;285:1711-8.
11. Cannon C, Braunwald E, McCabe C, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495-504.
12. Thomas E, Goldman L, Mangione CM, et al. Body mass index as a correlate of postoperative complications and resource utilization. Am J Med. 1997;102:277-83.
13. Bouillot J-L, Fingerhut A, Paquet J-C, Hay J-M, Coggia M. Are routine preoperative chest radiographs useful in general surgery? A prospective, multicentre study in 3959 patients. Eur J Surg. 1996;162:597-604.
14. Smetana GW, Macpherson DS. The case against routine preoperative laboratory testing. Med Clin N Am. 2003;87:7-40.
15. Warner MA, Offord KP, Warner ME, Lennon RL, Conover MA, Jansson-Schumacher U. Role of preoperative smoking cessation and other factors in postoperative pulmonary complications: a blinded prospective study of coronary artery bypass patients. Mayo Clin Proc. 1989;64:609-16.
16. Bluman LG, Mosca L, Newman N, Simon DG. Preoperative smoking habits and postoperative pulmonary complications. Chest. 1998;113:883-9.
17. Nakagawa M, Tanaka H, Tsukuma H, Kishi Y. Relationship between the duration of the preoperative smoke-free period and the incidence of post-operative pulmonary complications after pulmonary surgery. Chest. 2001;120:705-10.
18. Cheatham M, Chapman W, Key S, Sawyers J. A meta-analysis of selective versus routine nasogastric decompression after elective laparotomy. Ann Surg. 1995;221:469-76.
19. Geerts W, Pineo G, Heit J, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 suppl):338S-400S.
20. Mismetti P, Laporte S, Darmon J, Buchmuller A, Decousus H. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg. 2001;88:913-30.
21. Turpie A, Bauer K, Eriksson B, Lassen M. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med. 2002;162:1833-40.
22. Bergqvist D, Agnelli G, Cohen A, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002;346:975-80.
23. Cole M, Primeau F, McCusker J. Effectiveness of interventions to prevent delirium in hospitalized patients: a systematic review. Can Med Assoc J. 1996;155:1263-8.